MAX Chat
Boston Scientific
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
71.87 | 52.65 | 36.52% | 58.32 | +23.25% |
| P/S |
|
7.96 | 4.03 | 97.31% |
|
|
| P/BV |
|
6.06 | 10.87 | -44.27% |
|
|
| P/FCF |
|
57.66 | 39.64 | 45.47% |
|
|
| Ev/Ebitda |
|
37.34 | 16.1 | 131.87% |
|
|
| Ev/S |
|
8.6 | 4.35 | 97.57% |
|
|
| Ev/FCF |
|
54.44 | 52.31 | 4.07% |
|
|
| E/P |
|
0.0122 | 0.2095 | -94.2% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
23.03 | 19.07 | 20.71% | 23.07 | -0.1793% |
| ROE |
|
9.03 | -83.32 | -110.84% |
|
|
| ROA |
|
4.98 | 6.38 | -22% |
|
|
| ROIC |
|
4.77 | 15.06 | -68.33% |
|
|
| ROS |
|
11.07 | 9.34 | 18.59% |
|
|
| ROCE |
|
7.84 | 84.76 | -90.75% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
5/10
|
2.89 | 1.01 | 186.89% | 3.06 | -5.6% |
| Nеt Debt/Ebitda |
|
2.78 | 1.4 | 99.15% |
|
|
| Debt/Ratio |
|
0.283 | 0.2742 | 3.21% |
|
|
| Debt/Equity |
|
0.512 | 15.68 | -96.73% |
|
|
| Debt/Net Income |
|
6.01 | 6.8 | -11.6% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.28 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.75 | -100% | ||
| DSI |
|
0 | 0.7413 | -100% |
|
|
| Average dividend growth |
|
0 | -4.1 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.33 | -100% |
|
|
| Average percentage for payments |
|
11.35 | 44.08 | -74.25% |
|
|
| Difference from average difference in sector |
|
-1.28 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
68.99 | 12.47 | 453.25% | ||
| Growth impulse Ebitda in 5 years |
|
110.71 | -86.3 | -228.29% | ||
| Growth impulse Net Income in 5 years |
|
-1424.29 | -75.86 | 1777.52% | ||
| Growth impulse FCF in 5 years |
|
134.07 | -79.28 | -269.11% | ||
| Growth impulse EPS in 5 years |
|
-1362.88 | 4.34 | -31502.76% |
IP Score
3.63/10
